MedTrace Logo

Minimally Invasive Nasal Trabeculostomy: Long-Term Follow-Up Extension Study

NCT06612346 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36

Last updated 2025-01-10

No results posted yet for this study

Summary

This study is a follow-up extension study conducted in continuation of the prior MINT study (MMS-EEU-4), in which the long-term (i.e., 18, 24 months) clinical outcomes of Minimally Invasive Nasal Trabeculostomy (MINT) will be explored.

Conditions

Interventions

DEVICE

Minimally Invasive Micro Trabeculostomy

The MINT system is a surgical device designed to create a trabeculostomy within the eye.

Sponsors & Collaborators

  • Sanoculis Ltd

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-04
Primary Completion
2024-10-22
Completion
2024-12-31

Countries

  • Armenia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06612346 on ClinicalTrials.gov